about
The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease miceA novel neurotrophic drug for cognitive enhancement and Alzheimer's diseaseCNB-001 a novel curcumin derivative, guards dopamine neurons in MPTP model of Parkinson's disease.A novel Alzheimer's disease drug candidate targeting inflammation and fatty acid metabolism.Back to the future with phenotypic screeningThe cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.Effects of diet and/or exercise in enhancing spinal cord sensorimotor learning.β-dicarbonyl enolates: a new class of neuroprotectants.Delayed treatment with a novel neurotrophic compound reduces behavioral deficits in rabbit ischemic strokeEffect of the Pleiotropic Drug CNB-001 on Tissue Plasminogen Activator (tPA) Protease Activity in vitro: Support for Combination Therapy to Treat Acute Ischemic Stroke.J-147 a Novel Hydrazide Lead Compound to Treat Neurodegeneration: CeeTox(™) Safety and Genotoxicity Analysis.Emerging Therapies: Pleiotropic Multi-target Drugs to Treat Stroke VictimsSinomenine inhibits microglial activation by Aβ and confers neuroprotection.Stuck at the bench: Potential natural neuroprotective compounds for concussion.A pyrazole curcumin derivative restores membrane homeostasis disrupted after brain traumaBrain and spinal cord interaction: a dietary curcumin derivative counteracts locomotor and cognitive deficits after brain trauma.Application of the Hard and Soft, Acids and Bases (HSAB) theory to toxicant--target interactions.Drug-like property profiling of novel neuroprotective compounds to treat acute ischemic stroke: guidelines to develop pleiotropic moleculesModulation of 5-lipoxygenase in proteotoxicity and Alzheimer's disease.Mitochondrial metals as a potential therapeutic target in neurodegeneration.Novel curcumin derivative CNB-001 mitigates obesity-associated insulin resistance.Neuroprotective and neurotrophic curcuminoids to treat stroke: a translational perspective.Clinical development of curcumin in neurodegenerative disease.Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease.De-Risking of Stilbazulenyl Nitrone (STAZN), a Lipophilic Nitrone to Treat Stroke Using a Unique Panel of In Vitro Assays.Tomoregulin (TMEFF2) Binds Alzheimer's Disease Amyloid-β (Aβ) Oligomer and AβPP and Protects Neurons from Aβ-Induced Toxicity.CeeTox™ Analysis of CNB-001 a Novel Curcumin-Based Neurotrophic/Neuroprotective Lead Compound to Treat Stroke: Comparison with NXY-059 and Radicut.Fluorination Effects on NOS Inhibitory Activity of Pyrazoles Related to Curcumin.4-((1E)-2-(5-(4-hydroxy-3-methoxystyryl-)-1-phenyl-1H-pyrazoyl-3-yl) vinyl)-2-methoxy-phenol) (CNB-001) Does Not Regulate Human Recombinant Protein-Tyrosine Phosphatase1B (PTP1B) Activity in vitro.Metabolic links between diabetes and Alzheimer's disease.Insights into the Impact of a Membrane-Anchoring Moiety on the Biological Activities of Bivalent Compounds As Potential Neuroprotectants for Alzheimer's Disease.Decrease of Amyloid-β Levels by Curcumin Derivative via Modulation of Amyloid-β Protein Precursor Trafficking.A Potent Multi-functional Neuroprotective Derivative of Tetramethylpyrazine.
P2860
Q21195685-CB7C1856-DECE-46F2-9FDA-523BE750CB02Q28478380-D6994076-AEE0-45EE-BD95-03E52A0DD2C0Q33851011-5BDC4D97-C4F7-41B5-B27B-433FEB9A63C5Q33909566-D1DD33E8-1B74-47FF-8EC1-326FF3EED62FQ33918218-C1354C80-DA60-445D-AE28-813D1B81B71BQ34279067-B02930AC-4085-474A-A75E-41CC984DE152Q34387793-79AECEDD-171B-4540-A81C-F5BE76AEF2ABQ34388443-5FC8F9DE-9512-41E0-A9BC-4186167A7194Q34417300-4356E422-CEEC-4606-ADA9-4C260E808E12Q34432486-388F2CC6-7B47-443E-88A3-E6FE243F22EDQ34433111-7D1C96D0-6E5B-49E5-A5C0-DC8A11D99F8DQ35029799-465826F0-D6D6-464B-B056-B2C8A53FEDB4Q35240877-971D9078-E0B4-4AA5-8D6B-68D9B61E0F93Q35493114-32E259DB-FF0F-4CDE-8A32-C6A664124631Q35576201-4591702E-4F45-4297-8B85-2447E4FFC76AQ35672095-B9779750-7092-4E6D-8821-86E796EEF284Q35783273-926D00B0-08DB-4FF6-9C33-09D3B06799F1Q36841904-FDDE6105-6586-4C81-A562-231FF6D6202DQ36938297-56984188-8A74-436B-9162-C5F952518347Q37686294-CE2BD36F-077B-4365-A32E-A1722F66FA7DQ37707726-397519CF-5325-4809-9D1D-4C79B26B11C5Q37821005-79FDD2A5-794A-47F7-BAC3-73E60A41F38FQ38513024-AEB01FDB-F02E-465C-96AB-44009B6E348FQ38664541-A5444671-C06A-4CCB-A41C-C65F734C9BAFQ38681976-5470C62A-5360-4A07-B920-A00B421A1A58Q38832899-623541D8-46EF-402D-8165-3EF0E7CC7C80Q39558507-7AD9AE49-845C-4F16-9F31-EEFDB1C5185BQ40569105-ABA7F6F7-95A0-4CED-A3EE-D675277F772DQ42030786-7E24BE59-D9CE-471E-B545-B4ADB72AE2F1Q46032053-E77D37AE-AF28-4953-ACBB-11ADA2C1028EQ47899443-39595AC0-1511-4438-A8F0-B1A79ACA761EQ48393510-EA60C692-43D9-4395-8A91-0EAC079D5D8DQ50734809-729962A2-C556-4FFE-9083-D540836108E5
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A broadly neuroprotective derivative of curcumin.
@ast
A broadly neuroprotective derivative of curcumin.
@en
A broadly neuroprotective derivative of curcumin.
@nl
type
label
A broadly neuroprotective derivative of curcumin.
@ast
A broadly neuroprotective derivative of curcumin.
@en
A broadly neuroprotective derivative of curcumin.
@nl
prefLabel
A broadly neuroprotective derivative of curcumin.
@ast
A broadly neuroprotective derivative of curcumin.
@en
A broadly neuroprotective derivative of curcumin.
@nl
P2093
P2860
P1476
A broadly neuroprotective derivative of curcumin.
@en
P2093
David Schubert
Pamela Maher
Richard Dargusch
Yuanbin Liu
P2860
P304
P356
10.1111/J.1471-4159.2008.05236.X
P407
P577
2008-01-18T00:00:00Z